Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Croupier2on May 28, 2014 5:20pm
193 Views
Post# 22607373

RE:RE:Anybody going to the meeting

RE:RE:Anybody going to the meetingI think they are considering partnership (maybe had talks)<br /> <br /> likey scenario :<br /> <br /> If they hit safety, tolerence (already covered with its cash in hand) : they would receive $ and partner would pay for ph2..<br /> <br /> In this context the shelf could be a leverage in negociation, that or the big shareholders want to keep it for themselves...<br /> <br /> <br />
Bullboard Posts